Product image of Kofimucil Mucolitico (Acetylcysteine) supplied by GNH India

Kofimucil Mucolitico

Active Ingredient:
Acetylcysteine
Origin:
EU

Kofimucil Mucolitico (Acetylcysteine)

Acetylcysteine, the active ingredient in Kofimucil Mucolitico, is a mucolytic agent presented as an oral formulation for oral use. It works by breaking disulfide bonds in mucus glycoproteins, thereby decreasing mucus viscosity and facilitating clearance in acute and chronic respiratory conditions such as chronic bronchitis, chronic obstructive pulmonary disease and sinusitis.

GNH India supplies Kofimucil Mucolitico as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide with adherence to quality standards and regulatory requirements.

Manufacturer / TM Owner

Pool-Pharma S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Acetylcysteine is used as a mucolytic to improve mucus clearance in several respiratory disease categories.

  • Chronic bronchitis: reduces mucus thickness, aiding expectoration and relieving cough.
  • Chronic obstructive pulmonary disease (COPD): thins airway secretions to improve airflow and reduce exacerbations.
  • Sinusitis: lowers sinus mucus viscosity, facilitating drainage and symptom relief.
  • Acute respiratory infections: helps clear excessive mucus, supporting recovery.

How It Works

  • Acetylcysteine exerts its mucolytic effect by cleaving the disulfide bonds that link mucin glycoprotein subunits. This chemical reduction disrupts the three‑dimensional network of mucus, decreasing its viscoelasticity. The resulting thinner secretions are more easily moved by ciliary action and coughing, enhancing clearance from the respiratory tract. Additionally, the free sulfhydryl groups may contribute to antioxidant activity, though the primary therapeutic action in the respiratory system is mucus depolymerisation.

Side Effects

Acetylcysteine may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild stomach upset often occurring after oral intake.
  • Diarrhea: loose stools that may be transient.
  • Skin rash: mild erythema or itching.
  • Unpleasant odor: a characteristic sulfur‑like taste or breath.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction with difficulty breathing and swelling.
  • Bronchospasm: sudden narrowing of airways, especially in asthmatic patients.
  • Hepatic dysfunction: elevated liver enzymes or jaundice.
  • Angioedema: rapid swelling of face, lips or tongue.

Precautions & Warnings

When prescribing acetylcysteine, clinicians should consider several precautionary measures to ensure safe use.

  • Renal function: assess kidney status, dose may need adjustment in impairment.
  • Asthma or bronchospasm: monitor closely, avoid if active bronchospasm present.
  • Hypersensitivity: discontinue if allergic reaction occurs.
  • Concomitant nitroglycerin: avoid co‑administration due to risk of hypotension.
  • Pregnancy and lactation: use only if benefit outweighs risk.
  • Store at room temperature: keep in original packaging, protect from moisture.

Avoid Interactions

Acetylcysteine can interact with other medicines, affecting their efficacy or safety.

Major Interactions (Avoid)

  • Nitroglycerin: may cause profound hypotension when combined.
  • Activated charcoal: reduces acetylcysteine absorption if given concurrently.

Moderate Interactions (Monitor Closely)

  • Anticoagulants (e.g., warfarin): may increase bleeding tendency.
  • Antipsychotics (e.g., clozapine): potential for enhanced bronchospasm.
  • Oral contraceptives: possible reduction in hormonal effectiveness.

Frequently Asked Questions

Kofimucil Mucolitico contains acetylcysteine, a mucolytic agent that thins and loosens mucus in the respiratory tract. It is used to improve clearance of thick secretions in conditions such as chronic bronchitis, chronic obstructive pulmonary disease (COPD), sinusitis and other acute or chronic respiratory infections.

Acetylcysteine cleaves disulfide bonds within mucin glycoproteins, breaking the three‑dimensional network that gives mucus its high viscosity. This reduction in molecular cross‑linking makes the secretions less sticky and easier for ciliary action and coughing to transport out of the airways.

The appropriate dose of Kofimucil Mucolitico is determined by the prescribing clinician based on the patient’s specific condition, age, weight, renal function and other clinical factors. Patients should follow the exact regimen provided by their healthcare professional and not self‑adjust the dose.

Safety data for acetylcysteine in pregnancy and lactation are limited. It should only be used when the potential therapeutic benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified prescriber after evaluating the individual situation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India will verify institutional or trade credentials, then respond with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Acetylcysteine directly breaks disulfide bonds in mucus, providing rapid reduction in viscosity, whereas agents such as carbocisteine act mainly by modifying mucus production. The choice between them depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Kofimucil Mucolitico is an oral formulation taken by mouth, usually with a glass of water. The exact timing and frequency of administration are set by the prescribing clinician according to the patient’s condition and response to therapy.

Rare but serious adverse reactions include anaphylaxis, severe bronchospasm (especially in patients with asthma), hepatic dysfunction such as elevated liver enzymes or jaundice, and angioedema. Any signs of difficulty breathing, swelling of the face or lips, or yellowing of the skin should prompt immediate medical attention.

Individuals with a known hypersensitivity to acetylcysteine or any of the product’s excipients should avoid it. Patients experiencing active bronchospasm, severe asthma attacks, or those taking nitroglycerin without medical supervision should also refrain from use unless specifically directed by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.